Dreger and the colleagues reported significantly elevated CHI3L1 levels in ALS patients compared to healthy controls, with these levels correlating strongly with clinical measures of disease severity and the rate of motor decline [153]. Here, CHI3L1 is linked to amyotrophic lateral sclerosis.